Cancer Moonshot℠ - Recent Fiscal Year Funding
The 21st Century Cures Act, which was signed into law in December 2016, authorized $1.8 billion to fund the Cancer Moonshot over a 7 year period. The goal of the Cancer Moonshot is to accelerate progress in cancer, including prevention and screening, from cutting edge basic research to wider uptake of standard of care.
The following pages contain information on the $194 million of Cancer Moonshot funding received during Fiscal Year 2022.
More information on Cancer Moonshot can be found by visiting the NCI Cancer Moonshot Initiative page.
Information on recent funding opportunity announcements can be found on the Cancer Moonshot Funding Opportunities page.
| Fiscal Year | Authorization |
|---|---|
| 2017 | $300,000,000 |
| 2018 | $300,000,000 |
| 2019 |
$400,000,000 |
| 2020 |
$195,000,000 |
| 2021 |
$195,000,000 |
| 2022 |
$194,000,000 |
| 2023 |
$216,000,000 |
| Total | $1,800,000,000 |
Funding for the Cancer Moonshot is appropriated on an annual basis. The following pages contain information on the $194 million of Cancer Moonshot funding received during Fiscal Year 2022.
Obligations by Budget Mechanism
NCI reports Cancer Moonshot obligations by funding mechanism. See obligations for Moonshot grants, intramural research, and contracts, including the number of grant awards, funding amounts, and percentages by mechanism of the total budget authorized for Cancer Moonshot activities in FY 2022.
Funding by Research Category
The Cancer Moonshot Blue Ribbon Panel (BRP) provided research recommendations to accelerate progress against cancer. See the NCI obligations for Cancer Moonshot activities by research category.